R
R. Brian Sommerville
Researcher at Washington University in St. Louis
Publications - 11
Citations - 3942
R. Brian Sommerville is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Myopathy & Muscular dystrophy. The author has an hindex of 6, co-authored 11 publications receiving 3599 citations. Previous affiliations of R. Brian Sommerville include Princeton University.
Papers
More filters
Journal ArticleDOI
An fMRI Investigation of Emotional Engagement in Moral Judgment
Joshua D. Greene,R. Brian Sommerville,Leigh E. Nystrom,John M. Darley,Jonathan D. Cohen,Jonathan D. Cohen +5 more
TL;DR: It is argued that moral dilemmas vary systematically in the extent to which they engage emotional processing and that these variations in emotional engagement influence moral judgment.
Journal ArticleDOI
Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.
Matthew B. Harms,R. Brian Sommerville,Peggy Allred,Shaughn Bell,Duanduan Ma,Paul R. Cooper,Glenn Lopate,Alan Pestronk,Conrad C. Weihl,Robert H. Baloh +9 more
TL;DR: The causative gene in an autosomal dominant limb‐girdle muscular dystrophy with skeletal muscle vacuoles is identified and the mechanism behind the disease is elucidated.
Journal ArticleDOI
Multifocal radiculoneuropathy during ipilimumab treatment of melanoma
Georgios Manousakis,James Koch,R. Brian Sommerville,Ahmed El-Dokla,Matthew B. Harms,Mbbs Muhammad T. Al-Lozi Md,Robert E. Schmidt,Alan Pestronk +7 more
TL;DR: Ipilimumab toxicity presented as a monophasic, multifocal, asymmetric polyradiculoneuropathy involving roots and peripheral and cranial nerves with disruption of the blood–nerve barrier due to a microvasculopathy.
Journal ArticleDOI
CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA)
Rocio Garcia-Santibanez,Craig M. Zaidman,R. Brian Sommerville,Glenn Lopate,Conrad C. Weihl,Alan Pestronk,Robert C. Bucelli +6 more
TL;DR: Nerve ultrasound showed regional nerve enlargement and rituximab was the most effective immunomodulatory therapy in this cohort of CANOMAD/CANDA patients, indicating rare and debilitating disorders with characteristic clinical and diagnostic findings.
Journal ArticleDOI
Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS
TL;DR: Clinical and laboratory features of polyneuropathies in patients with serum IgM binding to the trisulfated disaccharide IdoA2S‐GlcNS‐6S (TS‐HDS) are studied.